Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 766

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 766
---
2023       |     |                 | 166 |
| Change in fair value estimate |     |                 |  20 |
| Balance – June 30, 2024       |     |                 | 186 |

8. Stockholders’ equity

Preferred stock

Series C Preferred Stock

|                                                        |     | Series C Preferred Stock |        |   |     |                 |        |   |
|                                                        |     | Numberof shares          |        |   |     | $(in thousands) |        |   |
| Balance – June 30, 2022                                |     |                          | 16,838 |   |     |                 | 12,275 |   |
| Conversion of Series C Preferred stock to common stock |     |                          | (2,630 | ) |     |                 | (1,909 | ) |
| Balance – June 30, 2023                                |     |                          | 14,208 |   |     |                 | 10,366 |   |
| Conversion of Series C Preferred stock to common stock |     |                          |   (540 | ) |     |                 |   (393 | ) |
| Balance – June 30, 2024                                |     |                          | 13,668 |   |     |                 |  9,973 |   |

In August 2020, the Company issued 25,028 shares of Series C Convertible Preferred Stock (the “Series C Preferred Stock”) in three separate closings of a private placement (Series C-1, C-2, and C-3). Each share of Series C Preferred Stock was issued at a purchase price of $ 1,000 per share and is convertible into shares of common stock based on the respective conversion prices which were determined at the closing of each round of the private placement. The conversion prices for the Series C-1 Preferred Stock, Series C-2 Preferred Stock, and the Series C-3 Preferred Stock are $ 58.00 , $ 60.70 , and $ 57.50 , respectively. Subject to ownership limitations, the owners of the Series C-1 Preferred Stock, the Series C-2 Preferred Stock, and the Series C-3 Preferred Stock are entitled to receive dividends, payable in shares of common stock at a rate of 10 %, 15 %, 20 % and 25 %,

<div align='center'>F-17</div>

respectively, of the number of shares of common stock iss